Risk Factors for Delayed Elimination of Methotrexate in Children, Adolescents and Young Adults With Osteosarcoma

Conclusion: Knowing the factors associated with delayed elimination of MTX could lead to safer and optimized chemotherapy for patients with osteosarcoma.

Source: In Vivo - November 3, 2020 Category: Research Authors: MISAKA, K., SUGA, Y., STAUB, Y., TSUBATA, A., SHIMADA, T., SAI, Y., MATSUSHITA, R. Tags: Clinical Studies Source Type: research